Literature DB >> 14523933

A brief introduction to cell-penetrating peptides.

Pontus Lundberg1, Ulo Langel.   

Abstract

Cell membranes act as protective walls to exclude most molecules that are not actively imported by living cells. This is an efficient way for a cell to prevent uncontrolled influx or efflux of solutes, which otherwise would be harmful to it. Only compounds within a narrow range of molecular size, polarity and net charge are able to diffuse effectively through cell membranes. In order to overcome this barrier for effective delivery of membrane-impermeable molecules, several chemical and physical methods have been developed. These methods, e.g. electroporation, and more recent methods as cationic lipids/liposomes, have been shown to be effective for delivering hydrophobic macromolecules. The drawbacks of these harsh methods are, primarily, the unwanted cellular effects exerted by them, and, secondly, their limitation to in vitro applications. The last decade's discovery of cell-penetrating peptides translocating themselves across cell membranes of various cell lines, along with a cargo 100-fold their own size, via a seemingly energy-independent process, opens up the possibility for efficient delivery of DNA, antisense peptide nucleic acids, oligonucleotides, proteins and small molecules into cells both in vitro and in vivo. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14523933     DOI: 10.1002/jmr.630

Source DB:  PubMed          Journal:  J Mol Recognit        ISSN: 0952-3499            Impact factor:   2.137


  40 in total

1.  Characterization of the cell-penetrating properties of the Epstein-Barr virus ZEBRA trans-activator.

Authors:  Romy Rothe; Lavinia Liguori; Ana Villegas-Mendez; Bruno Marques; Didier Grunwald; Emmanuel Drouet; Jean-Luc Lenormand
Journal:  J Biol Chem       Date:  2010-04-09       Impact factor: 5.157

2.  Transduction of the scorpion toxin maurocalcine into cells. Evidence that the toxin crosses the plasma membrane.

Authors:  Eric Estève; Kamel Mabrouk; Alain Dupuis; Sophia Smida-Rezgui; Xavier Altafaj; Didier Grunwald; Jean-Claude Platel; Nicolas Andreotti; Isabelle Marty; Jean-Marc Sabatier; Michel Ronjat; Michel De Waard
Journal:  J Biol Chem       Date:  2005-01-14       Impact factor: 5.157

3.  On the mechanisms of the internalization of S4(13)-PV cell-penetrating peptide.

Authors:  Miguel Mano; Cristina Teodósio; Artur Paiva; Sérgio Simões; Maria C Pedroso de Lima
Journal:  Biochem J       Date:  2005-09-01       Impact factor: 3.857

4.  Molecular dynamics simulations suggest a mechanism for translocation of the HIV-1 TAT peptide across lipid membranes.

Authors:  Henry D Herce; Angel E Garcia
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-18       Impact factor: 11.205

5.  Single quantum dot tracking reveals that an individual multivalent HIV-1 Tat protein transduction domain can activate machinery for lateral transport and endocytosis.

Authors:  Yasuhiro Suzuki; Chandra Nath Roy; Warunya Promjunyakul; Hiroyasu Hatakeyama; Kohsuke Gonda; Junji Imamura; Biju Vasudevanpillai; Noriaki Ohuchi; Makoto Kanzaki; Hideo Higuchi; Mitsuo Kaku
Journal:  Mol Cell Biol       Date:  2013-06-03       Impact factor: 4.272

6.  Cell penetrating peptides: how do they do it?

Authors:  Henry D Herce; Angel E Garcia
Journal:  J Biol Phys       Date:  2008-05-15       Impact factor: 1.365

7.  Dimeric cationic amphiphilic polyproline helices for mitochondrial targeting.

Authors:  Iris M Geisler; Jean Chmielewski
Journal:  Pharm Res       Date:  2011-06-07       Impact factor: 4.200

8.  Primary cardiomyocyte-targeted bioreducible polymer for efficient gene delivery to the myocardium.

Authors:  Hye Y Nam; Arlo McGinn; Pyung-Hwan Kim; Sung W Kim; David A Bull
Journal:  Biomaterials       Date:  2010-07-31       Impact factor: 12.479

9.  Free energy of translocating an arginine-rich cell-penetrating peptide across a lipid bilayer suggests pore formation.

Authors:  Kun Huang; Angel E García
Journal:  Biophys J       Date:  2013-01-22       Impact factor: 4.033

10.  A nuclear import inhibitory peptide ameliorates the severity of cholecystokinin-induced acute pancreatitis.

Authors:  Tamas Letoha; Csaba Somlai; Tamas Takacs; Annamaria Szabolcs; Katalin Jarmay; Zoltan Rakonczay; Peter Hegyi; Ilona Varga; Jozsef Kaszaki; Istvan Krizbai; Imre Boros; Erno Duda; Erzsebet Kusz; Botond Penke
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.